Close

Anti-YWHAG DNA-encoded mAb (DMAb), pVAX1 (DMAb-0094-LY)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-YWHAG DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • YWHAG
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

  • Entrez Gene ID
  • 7532
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-0311-LY 15B1 Mouse Human IgG Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0639-YJ 16C3 Mouse IgG Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0096-LY 2T1 Mouse IgG1 Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-415-YC 3F8 Mouse Human IgG1 Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0098-LY 505810 Mouse IgG2b Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0099-LY 63A1 Mouse Human IgG1 Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-827-YC 6A10 Mouse IgG2b, κ Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0122-LY 9A71 Mouse Human IgG2a Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0111-LY 9A70 Mouse Human IgG1, κ Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0199-LY KC21 Mouse Human IgG2a Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0188-LY J3H10 Mouse IgG2b, κ Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0177-LY HS23 Mouse IgG1, κ Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0166-LY CG31-2B6 Mouse IgG1 Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0085-LY CG15 Mouse Human IgG1 Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0144-LY AT4B9 Mouse IgG1, κ Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma
DMAb-0133-LY 9i237 Mouse IgG1, κ Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-YWHAG DNA-encoded mAb (DMAb), pVAX1 (DMAb-0094-LY). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.